BMW Group’s new Cell Recycling Competence Center (CRCC) in Salching in Lower Bavaria has now been officially commissioned – ...
During early development, tissues and organs begin to bloom through the shifting, splitting, and growing of many thousands of ...
Researchers at Karolinska Institutet and KTH have developed a computational method that can reveal how cells change and ...
In addition to CG001419, Cullgen continues the advancement of CG009301, a GSPT1 degrader being studied in a Phase 1 trial for the treatment of blood cancers, as well as progressing its pipeline of pre ...
Overall response rate (ORR) of 55% and median progression-free survival of 14.5 months in patients without TP53 gene mutationPhase 2 results ...
Carrick Therapeutics Inc., an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapies, today announced positive results from the Phase 2 SUMIT-BC clinical ...
Hormonal fluctuations throughout a woman's life are among the factors that most influence the immune system. Like a seesaw, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback